SND1 and prostate adenocarcinoma: The results suggested that SND1 was significantly overexpressed in various cancer tissues than that in the corresponding normal tissues, including colon adenocarcinoma (COAD), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), liver hepatocellular carcinoma (LIHC), prostate adenocarcinoma (PRAD), skin cutaneous melanoma (SKCM), testicular germ cell tumors (TGCT), thymoma (THYM), glioblastoma (GBM), and lower grade glioma (LGG).